Project Grant HT94252310298
Award Date
10/1/23
Completion Date
9/14/26
Dollars Obligated
$598K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Scottsdale, AZ 85259, USA
Similar Awards
The Defense Health Agency awarded a $408,467 Project Grant to Mayo Clinic Arizona, doing business as Mayo Clinic Hospital, for a research project titled "METABOLIC REPROGRAMMING OF CAR MACROPHAGES FOR OVARIAN CANCER IMMUNOTHERAPY." The award period runs from September 1, 2023, to August 31, 2025, under the Military Medical Research and Development (CFDA 12.420) federal grant program. The project aims to study the metabolic reprogramming of chimeric antigen receptor (CAR) macrophages to...
This federal Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) provides $3,291,419.00 to Mayo Clinic Arizona to conduct a Phase 1 clinical trial using autologous, MUC1-activated T cells expanded from peripheral blood in patients with relapsed and resistant ovarian cancer. The award period runs from September 1, 2024 to August 31, 2028. This research aims to advance innovative cellular immunotherapy approaches to transform...
The Defense Health Agency awarded a $1,162,900 Project Grant to the Mayo Clinic in Rochester, MN under the Military Medical Research and Development (CFDA 12.420) program. The grant, awarded on July 15, 2025, is for the project "LAUNCHING THE ERA OF MELANOMA SURVIVORSHIP: DEFINING TREATMENT TARGETS IN QUALITY OF LIFE AND MENTAL HEALTH" and runs through July 14, 2028. The grant supports advanced biomedical research aimed at transforming healthcare for military service members, veterans,...
The Mayo Clinic received a $278,250 project grant award from the Department of the Army Medical Command under the Military Medical Research and Development program. The grant will fund research from August 2021 through July 2025 to develop techniques for cytokine modulation of chimeric antigen receptor T cells to increase their safety and efficacy. The Military Medical Research and Development program aims to transform military and public health through innovative biomedical research solutions...
Mayo Clinic was awarded a $8,966,819 project grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant will support research from July 1, 2023 to June 30, 2027 to further develop purified exosome products for treating pulmonary damage from toxic exposures, leveraging Mayo Clinic's expertise in exosome applications. Through this funding, Mayo Clinic aims to advance biomedical solutions applicable to both military and civilian...
The Mayo Clinic was awarded a $1.7 million project grant from the Department of the Army Medical Command under the Military Medical Research and Development program. The grant will support research from August 2021 through July 2025 to develop techniques for cytokine modulation of chimeric antigen receptor T cells to increase their safety and efficacy. The Military Medical Research and Development program aims to transform military and public health through innovative biomedical research...
The Defense Health Agency has awarded a $968,400 Project Grant to Mayo Clinic to develop a personalized approach to treating drug-resistant ovarian cancer. The grant, which began on June 1, 2024, and will run through May 31, 2028, is funded under the Military Medical Research and Development program (CFDA 12.420). This program supports biomedical research to improve the health and care of military service members, veterans, and their families. Through this award, Mayo Clinic will leverage its...
This Project Grant award, provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. The $424,565 award to Mayo Clinic, a renowned non-profit academic medical center, will fund research to investigate the clinical significance of somatic genetic variants in telomere biology disorders over a 3-year period...
The federal Project Grant award of $161,400.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) will support Mayo Clinic's research project titled "AN ATLAS OF THE TUMOR IMMUNE CIRCULOME." This award, with a performance period from June 1, 2024 to May 31, 2025, aims to advance medical knowledge and improve patient care through innovative biomedical research. The Military Medical Research and Development program funds a wide range of...
The Defense Health Agency awarded Mayo Clinic Jacksonville $3,232,027 under the Military Medical Research and Development federal grant program (CFDA 12.420) from September 15, 2023 through September 14, 2027. Through this award, Mayo Clinic will integrate molecular pathology, radiology, and genetics to improve breast cancer risk prediction. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform health care for service members...